Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Omadacycline.

Literature DB >> 30923399

Omadacycline.

Abstract

Each month, subscribers to The Formulary Monograph Service receive 5 to 6 well-documented monographs on drugs that are newly released or are in late phase 3 trials. The monographs are targeted to Pharmacy & Therapeutics Committees. Subscribers also receive monthly 1-page summary monographs on agents that are useful for agendas and pharmacy/nursing in-services. A comprehensive target drug utilization evaluation/medication use evaluation (DUE/MUE) is also provided each month. With a subscription, the monographs are available online to subscribers. Monographs can be customized to meet the needs of a facility. Through the cooperation of The Formulary, Hospital Pharmacy publishes selected reviews in this column. For more information about The Formulary Monograph Service, contact Wolters Kluwer customer service at 866-397-3433.

Entities: Chemical

Keywords: Anti-infectives; Drug Information; Formulary Management / P & T

Year: 2019 PMID： 30923399 PMCID： PMC6431718 DOI： 10.1177/0018578718823730

Source DB: PubMed Journal: Hosp Pharm ISSN： 0018-5787

Keyword Cloud
References

23 in total

1. Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults.

Authors: Lionel A Mandell; Richard G Wunderink; Antonio Anzueto; John G Bartlett; G Douglas Campbell; Nathan C Dean; Scott F Dowell; Thomas M File; Daniel M Musher; Michael S Niederman; Antonio Torres; Cynthia G Whitney
Journal: Clin Infect Dis Date: 2007-03-01 Impact factor: 9.079

2. Clinical disposition, metabolism and in vitro drug-drug interaction properties of omadacycline.

Authors: Jimmy Flarakos; Yancy Du; Helen Gu; Lai Wang; Heidi J Einolf; Dung Y Chun; Bing Zhu; Natalia Alexander; Adrienne Natrillo; Imad Hanna; Lillian Ting; Wei Zhou; Kiran Dole; Haiying Sun; Steven J Kovacs; Daniel S Stein; S Ken Tanaka; Stephen Villano; James B Mangold
Journal: Xenobiotica Date: 2016-08-08 Impact factor: 1.908

3. Practice guidelines for the diagnosis and management of skin and soft tissue infections: 2014 update by the Infectious Diseases Society of America.

Authors: Dennis L Stevens; Alan L Bisno; Henry F Chambers; E Patchen Dellinger; Ellie J C Goldstein; Sherwood L Gorbach; Jan V Hirschmann; Sheldon L Kaplan; Jose G Montoya; James C Wade
Journal: Clin Infect Dis Date: 2014-07-15 Impact factor: 9.079

4. Mechanism of action of the novel aminomethylcycline antibiotic omadacycline.

Authors: Michael P Draper; S Weir; A Macone; J Donatelli; C A Trieber; S K Tanaka; Stuart B Levy
Journal: Antimicrob Agents Chemother Date: 2013-09-16 Impact factor: 5.191

5. A randomized, evaluator-blind, phase 2 study comparing the safety and efficacy of omadacycline to those of linezolid for treatment of complicated skin and skin structure infections.

Authors: Gary J Noel; Michael P Draper; Howard Hait; S Ken Tanaka; Robert D Arbeit
Journal: Antimicrob Agents Chemother Date: 2012-08-20 Impact factor: 5.191

10. The Novel Aminomethylcycline Omadacycline Has High Specificity for the Primary Tetracycline-Binding Site on the Bacterial Ribosome.

Authors: Corina G Heidrich; Sanya Mitova; Andreas Schedlbauer; Sean R Connell; Paola Fucini; Judith N Steenbergen; Christian Berens
Journal: Antibiotics (Basel) Date: 2016-09-22

Omadacycline.

1. Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults.

2. Clinical disposition, metabolism and in vitro drug-drug interaction properties of omadacycline.

3. Practice guidelines for the diagnosis and management of skin and soft tissue infections: 2014 update by the Infectious Diseases Society of America.

4. Mechanism of action of the novel aminomethylcycline antibiotic omadacycline.

5. A randomized, evaluator-blind, phase 2 study comparing the safety and efficacy of omadacycline to those of linezolid for treatment of complicated skin and skin structure infections.

Review 6. Discovery, pharmacology, and clinical profile of omadacycline, a novel aminomethylcycline antibiotic.

7. In vitro and in vivo antibacterial activities of omadacycline, a novel aminomethylcycline.

8. In Vitro and In Vivo Assessments of Cardiovascular Effects with Omadacycline.

9. Effect of Food on the Bioavailability of Omadacycline in Healthy Participants.

10. The Novel Aminomethylcycline Omadacycline Has High Specificity for the Primary Tetracycline-Binding Site on the Bacterial Ribosome.